Letter: contraindicated drug-drug interactions before and after initiation of direct-acting anti-viral agents in chronic hepatitis C patients in Taiwan. Authors’ reply
Journal
Alimentary Pharmacology and Therapeutics
Journal Volume
50
Journal Issue
1
Pages
115-116
Date Issued
2019
Author(s)
SDGs
Other Subjects
antivirus agent; asunaprevir plus daclatasvir; dasabuvir plus ombitasvir plus paritaprevir plus ritonavir; unclassified drug; antivirus agent; interferon; chronic hepatitis C; data base; drug contraindication; drug dose regimen; human; Letter; personalized medicine; priority journal; Taiwan; chronic hepatitis C; drug interaction; hepatitis C; Antiviral Agents; Drug Interactions; Hepatitis C; Hepatitis C, Chronic; Humans; Interferons; Taiwan
Publisher
Blackwell Publishing Ltd
Type
letter